Ljungman S, Aurell M, Hartford M, Wikstrand J, Berglund G
Department of Nephrology, Sahlgrenska Hospital, University of Göteborg.
Drugs. 1988;35 Suppl 5:55-8. doi: 10.2165/00003495-198800355-00009.
Glomerular filtration rate (GFR) and renal plasma flow (inulin and para-aminohippurate clearance) were measured in a random sample of 17 normotensive and 20 untreated patients with primary hypertension. At the 7-year follow-up, 19 patients were on metoprolol (as the sole drug or in combination with either hydrochlorothiazide or hydralazine) and 1 patient was on hydrochlorothiazide. They were re-examined after withdrawal of treatment and return of hypertension. At the 7-year follow-up GFR was more reduced in the hypertensive (-17%) than in the normotensive group (-9%). The percentage decrease in renal blood flow was the same in both groups. No significant renal function changes appeared after withdrawal of treatment. In conclusion, there was a slightly greater deterioration in GFR in the hypertensive patients after long term treatment with metoprolol than can be explained by normal ageing.
对17名血压正常者和20名未经治疗的原发性高血压患者的随机样本测量了肾小球滤过率(GFR)和肾血浆流量(菊粉和对氨基马尿酸清除率)。在7年随访时,19名患者服用美托洛尔(作为单一药物或与氢氯噻嗪或肼屈嗪联合使用),1名患者服用氢氯噻嗪。在停药且高血压复发后对他们进行了复查。在7年随访时,高血压组的GFR降低幅度(-17%)大于血压正常组(-9%)。两组肾血流量的降低百分比相同。停药后未出现明显的肾功能变化。总之,高血压患者长期服用美托洛尔后GFR的恶化程度略大于正常衰老所能解释的程度。